MX360001B - Compuestos de acrilamida como ligandos receptores de histamina h3. - Google Patents
Compuestos de acrilamida como ligandos receptores de histamina h3.Info
- Publication number
- MX360001B MX360001B MX2015000064A MX2015000064A MX360001B MX 360001 B MX360001 B MX 360001B MX 2015000064 A MX2015000064 A MX 2015000064A MX 2015000064 A MX2015000064 A MX 2015000064A MX 360001 B MX360001 B MX 360001B
- Authority
- MX
- Mexico
- Prior art keywords
- histamine
- receptor ligands
- acrylamide compounds
- compounds
- formula
- Prior art date
Links
- 102000004384 Histamine H3 receptors Human genes 0.000 title abstract 2
- 108090000981 Histamine H3 receptors Proteins 0.000 title abstract 2
- 150000003926 acrylamides Chemical class 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se relaciona con compuestos novedosos de acrilamida de fórmula (I), y sus sales farmacéuticamente aceptables y el proceso para su preparación. (ver Fórmula) Los compuestos de fórmula (I) son útiles en el tratamiento de varios trastornos que se relacionan con receptores de histamina H3.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3464CH2012 | 2012-08-23 | ||
| PCT/IN2012/000796 WO2014030170A1 (en) | 2012-08-23 | 2012-12-05 | Acrylamide compounds as histamine h3 receptor ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015000064A MX2015000064A (es) | 2015-04-08 |
| MX360001B true MX360001B (es) | 2018-10-18 |
Family
ID=54187093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015000064A MX360001B (es) | 2012-08-23 | 2012-12-05 | Compuestos de acrilamida como ligandos receptores de histamina h3. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US9328092B2 (es) |
| EP (1) | EP2888243B1 (es) |
| JP (1) | JP5981654B2 (es) |
| KR (1) | KR101707343B1 (es) |
| CN (1) | CN104540812B (es) |
| AP (1) | AP2014008139A0 (es) |
| AU (1) | AU2012388383C1 (es) |
| BR (1) | BR112015001524B1 (es) |
| CA (1) | CA2878217C (es) |
| CY (1) | CY1118035T1 (es) |
| DK (1) | DK2888243T3 (es) |
| EA (1) | EA025136B1 (es) |
| ES (1) | ES2592819T3 (es) |
| HR (1) | HRP20161167T1 (es) |
| HU (1) | HUE030901T2 (es) |
| IL (1) | IL236437A (es) |
| LT (1) | LT2888243T (es) |
| ME (1) | ME02519B (es) |
| MX (1) | MX360001B (es) |
| PL (1) | PL2888243T3 (es) |
| PT (1) | PT2888243T (es) |
| RS (1) | RS55158B1 (es) |
| SG (1) | SG11201408423XA (es) |
| SI (1) | SI2888243T1 (es) |
| SM (1) | SMT201600336B (es) |
| WO (1) | WO2014030170A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11313246B2 (en) | 2016-11-30 | 2022-04-26 | General Electric Company | Gas turbine engine wash system |
| WO2022113008A1 (en) | 2020-11-27 | 2022-06-02 | Richter Gedeon Nyrt. | Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder |
| EP4488263A2 (en) | 2022-03-02 | 2025-01-08 | Hangzhou Bio-Sincerity Pharma-tech Co., Ltd. | Phenylurea derivative and pharmaceutical use thereof |
| KR20250016079A (ko) | 2022-03-02 | 2025-02-03 | 항저우 바이오-신세리티 파마-테크 컴퍼니 리미티드 | 히스타민 h3 수용체 길항제 및 이의 약학적 용도 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0410657A (pt) * | 2003-06-12 | 2006-06-20 | Novo Nordisk As | composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto |
| US8008301B2 (en) | 2004-04-01 | 2011-08-30 | Eli Lilly And Company | Histamine H3 receptor agents, preparation and therapeutic uses |
| AU2005249196B2 (en) * | 2004-06-02 | 2011-06-09 | F. Hoffmann-La Roche Ag | Naphthaline derivatives useful as histamine-3-receptor ligands |
| CA2569611C (en) * | 2004-06-21 | 2012-12-11 | F. Hoffmann-La Roche Ag | Indole derivatives as histamine receptor antagonists |
| MX2007002274A (es) | 2004-08-23 | 2007-05-07 | Lilly Co Eli | Agentes del receptor de histamina h3. preparacion y usos terapeuticos. |
| EP1968967B1 (en) * | 2005-11-30 | 2011-04-27 | F. Hoffmann-La Roche AG | 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| AU2007267184A1 (en) | 2006-05-30 | 2007-12-06 | F. Hoffmann-La Roche Ag | Piperidinyl pyrimidine derivatives |
| US7534788B2 (en) * | 2007-07-25 | 2009-05-19 | Hoffmann-La Roche Inc. | Benzofuran and benzothiophene-2-carboxylic acid amide derivatives |
| CN101848903A (zh) | 2007-09-06 | 2010-09-29 | 葛兰素集团有限公司 | 对组胺h3受体具有亲和性的哌嗪衍生物 |
| WO2009100120A2 (en) | 2008-02-04 | 2009-08-13 | Neurogen Corporation | Pyridinyl-substituted piperazinyl oxoethyl tetrahydropyrazolopyridines |
| CN102046624A (zh) | 2008-03-31 | 2011-05-04 | 埃沃特克股份有限公司 | 作为组胺h3受体拮抗剂的四氢萘啶及其氮杂衍生物 |
| EP2300422B1 (en) | 2008-05-08 | 2014-11-05 | Evotec AG | Azetidines as histamine h3 receptor antagonists |
| HUE028435T2 (en) * | 2010-09-02 | 2016-12-28 | Suven Life Sciences Ltd | Heterocyclic compounds as histamine H3 receptor ligands |
-
2012
- 2012-12-05 PL PL12844650T patent/PL2888243T3/pl unknown
- 2012-12-05 US US14/419,474 patent/US9328092B2/en active Active
- 2012-12-05 AP AP2014008139A patent/AP2014008139A0/xx unknown
- 2012-12-05 ES ES12844650.7T patent/ES2592819T3/es active Active
- 2012-12-05 WO PCT/IN2012/000796 patent/WO2014030170A1/en not_active Ceased
- 2012-12-05 SI SI201230707A patent/SI2888243T1/sl unknown
- 2012-12-05 KR KR1020157001952A patent/KR101707343B1/ko active Active
- 2012-12-05 LT LTEP12844650.7T patent/LT2888243T/lt unknown
- 2012-12-05 HR HRP20161167TT patent/HRP20161167T1/hr unknown
- 2012-12-05 AU AU2012388383A patent/AU2012388383C1/en active Active
- 2012-12-05 SG SG11201408423XA patent/SG11201408423XA/en unknown
- 2012-12-05 MX MX2015000064A patent/MX360001B/es active IP Right Grant
- 2012-12-05 EA EA201590413A patent/EA025136B1/ru unknown
- 2012-12-05 DK DK12844650.7T patent/DK2888243T3/en active
- 2012-12-05 PT PT128446507T patent/PT2888243T/pt unknown
- 2012-12-05 RS RS20160783A patent/RS55158B1/sr unknown
- 2012-12-05 HU HUE12844650A patent/HUE030901T2/en unknown
- 2012-12-05 JP JP2015528009A patent/JP5981654B2/ja active Active
- 2012-12-05 CA CA2878217A patent/CA2878217C/en active Active
- 2012-12-05 EP EP12844650.7A patent/EP2888243B1/en active Active
- 2012-12-05 ME MEP-2016-190A patent/ME02519B/me unknown
- 2012-12-05 BR BR112015001524-7A patent/BR112015001524B1/pt active IP Right Grant
- 2012-12-05 CN CN201280075253.4A patent/CN104540812B/zh active Active
-
2014
- 2014-12-24 IL IL236437A patent/IL236437A/en active IP Right Grant
-
2016
- 2016-09-22 CY CY20161100943T patent/CY1118035T1/el unknown
- 2016-09-23 SM SM201600336T patent/SMT201600336B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201391332A1 (ru) | Лиганды опиоидных рецепторов и способы их применения и получения | |
| TN2014000138A1 (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. | |
| PH12015502615B1 (en) | Chemical compounds | |
| PH12015501920B1 (en) | USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kd RELATED DISORDERS | |
| MX2013012652A (es) | Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparacion y su uso como antagonistas p2y12. | |
| MX2014002683A (es) | Derivados de benzonitrilo como inhibidores de cinasa. | |
| MX2014000779A (es) | Derivados de carboxamida y urea que contienen pirazol heteroaromatico sustituido como ligandos del receptor de vanilloide. | |
| MX2014000964A (es) | Derivados aza heterociclicos sustituidos. | |
| GEP201706690B (en) | Novel process for making compounds for use in treatment of cancer | |
| TN2015000120A1 (en) | Oxazolidin-2-one-pyrimidine derivatives | |
| EA201391056A1 (ru) | Гетероарильные соединения в качестве лигандов 5-htрецептора | |
| MX2014002832A (es) | Nuevas imidazol-aminas como moduladores de la actividad de cinasas. | |
| PH12014501195A1 (en) | Novel 2h-indazoles as ep2, receptor antagonists | |
| TW201613884A (en) | Selective NR2B antagonists | |
| MX339460B (es) | Derivados de benzazol como ligandos del receptor h4 de histamina. | |
| MX339858B (es) | Compuestos novedosos como ligandos del receptor h3 de la histamina. | |
| TN2013000420A1 (en) | 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors | |
| MX2015000064A (es) | Compuestos de acrilamida como ligandos receptores de histamina h3. | |
| EA201491878A1 (ru) | Замещенные ксантиновые производные | |
| EA201390327A1 (ru) | Гетероциклильные соединения в качестве лигандов гистаминовых hрецепторов | |
| MX2014003455A (es) | Derivados de metanosulfonamida sustituidos con arilo o n-heteroarilo como ligandos de receptor vanilloide. | |
| WO2013048949A3 (en) | Selective nr2b antagonists | |
| MX2018004256A (es) | Antagonistas de receptor de n-metil-d-aspartato subtipo 2b (nr2b) selectivos. | |
| MX2015005312A (es) | Derivados de 1h-indazol-3-carboxamida y uso de los mismos como antagonistas de p2y12. | |
| EA033160B1 (ru) | Соединения для лечения заболеваний, связанных с ишемией-реперфузией |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |